Rudat V - Search Results

1

[Immunohistochemical determination of cell cycle regulatory proteins. No prognostic significance in advanced squamous epithelial carcinomas of the head-neck area].

Kunz C, Bosch FX, Klein-Kühne W, Nollert J, Rudat V, Conradt C, Dietz A. Kunz C, et al. Among authors: rudat v. HNO. 2003 Oct;51(10):800-5. doi: 10.1007/s00106-003-0818-x. Epub 2003 Apr 9. HNO. 2003. PMID: 14523533 German.

2

[The problem of radiogenic and chemotherapy-induced mucositis of the mouth and and oropharynx exemplified by accelerated radiochemotherapy with carboplatin in patients with inoperable squamous epithelial carcinomas of the head-/neck area. Heidelberg experiences].

Dietz A, Nollert J, Maier H, Rudat V, Flentje M. Dietz A, et al. Among authors: rudat v. HNO. 1995 Jul;43(7):403-13. HNO. 1995. PMID: 7545657 German.

3

[Polarographic detection of reoxygenation of lymph node metastases in the initial phase of primary radio- and radiochemotherapy in patients with advanced squamous epithelial carcinomas of the head and neck].

Vanselow B, Dietz A, Rudat V, Wollensack P, Bettscheider C, Eble MJ. Vanselow B, et al. Among authors: rudat v. HNO. 1997 Mar;45(3):140-6. doi: 10.1007/s001060050103. HNO. 1997. PMID: 9417437 German.

4

[Chronic laryngeal edema as a late reaction to radiochemotherapy].

Dietz A, Rudat V, Nollert J, Helbig M, Vanselow B, Weidauer H. Dietz A, et al. Among authors: rudat v. HNO. 1998 Aug;46(8):731-8. doi: 10.1007/s001060050303. HNO. 1998. PMID: 9773329 German.

5

[Predictive value of serum levels of basic fibroblast growth factor, vascular endothelial growth factor and matrix metalloproteinase-2 in advanced carcinomas of the head and neck].

Dietz A, Rudat V, Vanselow B, Conradt C, Möhler T. Dietz A, et al. Among authors: rudat v. HNO. 1999 Aug;47(8):695-701. doi: 10.1007/s001060050447. HNO. 1999. PMID: 10506495 German.

6

[Prognostic significance of cell-cycle regulatory proteins for outcome after primary radiochemotherapy in patients with advanced head and neck cancer].

Haas S, Bosch FX, Klein-Kühne W, Nollert J, Rudat V, Conradt C, Dietz A. Haas S, et al. Among authors: rudat v. HNO. 1999 Sep;47(9):777-86. doi: 10.1007/s001060050460. HNO. 1999. PMID: 10525606 Clinical Trial. German.

7

[Effect of primary radiochemotherapy on cellular and subcellular immunologic parameters].

Nollert J, Rudat V, Daniel V, Maier H, Dietz A. Nollert J, et al. Among authors: rudat v. HNO. 1999 Dec;47(12):1058-62. doi: 10.1007/s001060050491. HNO. 1999. PMID: 10654183 Clinical Trial. German.

8

Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.

Rudat V, Dietz A, Schramm O, Conradt C, Maier H, Flentje M, Wannenmacher M. Rudat V, et al. Radiother Oncol. 1999 Nov;53(2):119-25. doi: 10.1016/s0167-8140(99)00119-x. Radiother Oncol. 1999. PMID: 10665788 Clinical Trial.

9

Oxygenation of advanced head and neck cancer: prognostic marker for the response to primary radiochemotherapy.

Vanselow B, Eble MJ, Rudat V, Wollensack P, Conradt C, Dietz A. Vanselow B, et al. Among authors: rudat v. Otolaryngol Head Neck Surg. 2000 Jun;122(6):856-62. doi: 10.1016/S0194-59980070014-3. Otolaryngol Head Neck Surg. 2000. PMID: 10828799

10

[Prognostic value of hemoglobin level for primary radiochemotherapy of head-neck carcinomas].

Dietz A, Rudat V, Conradt C, Vanselow B, Wollensack P, Staar S, Eckel H, Volling P, Schröder M, Wannenmacher M, Müller RP, Weidauer H. Dietz A, et al. Among authors: rudat v. HNO. 2000 Sep;48(9):655-64. doi: 10.1007/s001060050635. HNO. 2000. PMID: 11056853 Clinical Trial. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters